Citius Pharmaceuticals to Host Investor Webcast to Discuss the Acquisition of Late Phase 3 Cancer Immunotherapy I/ONTAK (E7777)

/PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR) today announced that it will host a webcast on October 20, 2021 at 8:30...

Related Keywords

Japan ,Ilanit Allen ,Jaime Bartushak ,Myron Holubiak ,Myron Czuczman ,Leonard Mazur ,Novecite Inc ,Company Nasdaq ,Drug Administration ,Us Toll International ,Citius Pharmaceuticals ,Exchange Commission ,Securities Exchange ,Investor Relations For Citius Pharmaceuticals ,Citius Pharmaceuticals Inc ,Investor Relations Corporate Communications ,Chief Executive Officer ,Executive Chairman ,Chief Medical Officer ,Chief Financial Officer ,Pivotal Phase ,Fast Track ,Securities Act ,Securities Exchange Act ,Annual Report ,Investor Relations ,Nc ,